Trials / Completed
CompletedNCT00683332
Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)
A Prospective, Observational Study To Monitor Safety In Patients Who Were Administered With Tigecycline (Tygacil) 50 mg By Intravenous Injection (An Observational Study for Safety - Monitored Release)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 621 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.
Detailed description
Three-thousand or 10% of total number of patients given tigecycline will be included in the study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tigecycline (Tygacil) | This is a non-interventional study; patients are administered Tygacil as prescribed by their doctor as per registered indications stated in product label/insert (50 mg by Intravenous Injection). |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2008-05-23
- Last updated
- 2011-07-08
- Results posted
- 2011-07-08
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT00683332. Inclusion in this directory is not an endorsement.